BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10219800)

  • 1. Assessing the cost-effectiveness of postmastectomy radiation therapy.
    Marks LB; Hardenbergh PH; Winer ET; Prosnitz LR
    Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):91-8. PubMed ID: 10219800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation the significance of tumor size.
    Fodor J; Polgár C; Major T; Németh G
    Strahlenther Onkol; 2003 Mar; 179(3):197-202. PubMed ID: 12627264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locoregional failure of postmastectomy patients with 1-3 positive axillary lymph nodes without adjuvant radiotherapy.
    Cheng JC; Chen CM; Liu MC; Tsou MH; Yang PS; Jian JJ; Cheng SH; Tsai SY; Leu SY; Huang AT
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):980-8. PubMed ID: 11958892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation.
    Woodward WA; Strom EA; Tucker SL; Katz A; McNeese MD; Perkins GH; Buzdar AU; Hortobagyi GN; Hunt KK; Sahin A; Meric F; Sneige N; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):336-44. PubMed ID: 12957243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal impact of postmastectomy radiation therapy on locoregional recurrence for breast cancer patients with 1 to 3 positive lymph nodes in the modern treatment era.
    Miyashita M; Tada H; Suzuki A; Watanabe G; Hirakawa H; Amari M; Kakugawa Y; Kawai M; Furuta A; Sato K; Yoshida R; Ebata A; Sasano H; Jingu K; Ohuchi N; Ishida T
    Surg Oncol; 2017 Jun; 26(2):163-170. PubMed ID: 28577722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axillary lymph node status, but not tumor size, predicts locoregional recurrence and overall survival after mastectomy for breast cancer.
    Beenken SW; Urist MM; Zhang Y; Desmond R; Krontiras H; Medina H; Bland KI
    Ann Surg; 2003 May; 237(5):732-8; discussion 738-9. PubMed ID: 12724640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loco-regional recurrence after mastectomy in high-risk breast cancer--risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials.
    Nielsen HM; Overgaard M; Grau C; Jensen AR; Overgaard J
    Radiother Oncol; 2006 May; 79(2):147-55. PubMed ID: 16647152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locoregional recurrence risk factors and the impact of postmastectomy radiotherapy on patients with tumors 5 cm or larger.
    Nagao T; Kinoshita T; Tamura N; Hojo T; Morota M; Kagami Y
    Breast Cancer; 2014 May; 21(3):292-301. PubMed ID: 22890603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Postmastectomy radiotherapy for early breast cancer].
    Wang S; Li Y; Yu Z
    Zhonghua Zhong Liu Za Zhi; 2002 Jan; 24(1):68-70. PubMed ID: 11977644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of apex axillary invasion for locoregional recurrence and effect of postmastectomy radiotherapy on overall survival in node-positive breast cancer patients.
    Kuru B; Camlibel M; Dinc S; Gulcelik MA; Alagol H
    World J Surg; 2004 Mar; 28(3):236-41. PubMed ID: 14961194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decision-analytic model and cost-effectiveness evaluation of postmastectomy radiation therapy in high-risk premenopausal breast cancer patients.
    Lee JH; Glick HA; Hayman JA; Solin LJ
    J Clin Oncol; 2002 Jun; 20(11):2713-25. PubMed ID: 12039934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of radiation therapy following conservative surgery for ductal carcinoma in situ of the breast.
    Suh WW; Hillner BE; Pierce LJ; Hayman JA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1054-61. PubMed ID: 15752884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer.
    Truong PT; Olivotto IA; Speers CH; Wai ES; Berthelet E; Kader HA
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):797-804. PubMed ID: 14967436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
    Truong PT; Jones SO; Kader HA; Wai ES; Speers CH; Alexander AS; Olivotto IA
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):357-64. PubMed ID: 18676091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials.
    Overgaard M; Nielsen HM; Overgaard J
    Radiother Oncol; 2007 Mar; 82(3):247-53. PubMed ID: 17306393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locoregional recurrence in patients with one to three positive axillary nodes after mastectomy without adjuvant radiotherapy.
    Cheng JC; Chen CM; Liu MC; Tsou MH; Yang PS; Cheng SH
    J Formos Med Assoc; 2000 Oct; 99(10):759-65. PubMed ID: 11061070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of local-regional radiotherapy with conventional or high-dose chemotherapy in the management of breast cancer patients with > or = 10 positive axillary nodes.
    Jabro G; Wazer DE; Ruthazer R; Lum R; Sklar N; Goldman D; Enegess D; Erban J
    Int J Radiat Oncol Biol Phys; 1999 May; 44(2):273-80. PubMed ID: 10760419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes.
    Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA
    Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1-3 positive nodes: an analysis of prospective data from British Columbia and the M. D. Anderson Cancer Center.
    Truong PT; Woodward WA; Thames HD; Ragaz J; Olivotto IA; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):59-65. PubMed ID: 17321065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.